Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • BeiGene cancer news

    BeiGene Co. Ltd., Beijing, China Business: Cancer BeiGene said it is establishing a biomanufacturing facility in BioBay, an innovation hub located in the Suzhou Industrial Park of Suzhou, China. It expects the cGMP …

    Published on 8/24/2015
  • Bristol-Myers, Pfizer cardiovascular news

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Cardiovascular Hedge fund manager Kyle Bass is challenging a patent on Eliquis apixaban from Bristol-Myers and Pfizer …

    Published on 8/24/2015
  • Celltrion, Roche autoimmune, biosimilars news

    Celltrion Inc. (KOSDAQ:068270), Incheon, South Korea Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Autoimmune, Biosimilars Celltrion filed an inter partes review (IPR) petition with the U.S. Patent and …

    Published on 8/24/2015
  • Illumina, Warburg Pincus, Sutter Hill Ventures genomics news

    Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Warburg Pincus LLC, New York, N.Y. Sutter Hill Ventures, Palo Alto, Calif. Business: Genomics Consumer genomics company Helix Opco LLC (San Francisco, Calif.) debuted last …

    Published on 8/24/2015
  • Kite Pharma, Memorial Sloan Kettering cancer news

    Kite Pharma Inc. (NASDAQ:KITE), Los Angeles, Calif. Memorial Sloan Kettering Cancer Center (MSKCC), New York, N.Y. Business: Cancer Kite filed an inter partes review (IPR) petition with the U.S. Patent and Trademark …

    Published on 8/24/2015
  • Lundbeck neurology news

    H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Business: Neurology Lundbeck will reduce headcount by about 1,000 (17%) to about 4,801 to cut costs and regain profitability. The restructuring is Lundbecks first major …

    Published on 8/24/2015
  • Lupin, Pozen autoimmune news

    Lupin Ltd. (NSE:LUPIN; BSE:500257), Mumbai, India Pozen Inc. (NASDAQ:POZN), Chapel Hill, N.C. Business: Autoimmune Lupin filed three inter partes review (IPR) petitions with the U.S. Patent and Trademark Office …

    Published on 8/24/2015
  • Pfenex, U.S. Department of Health and Human Services infectious news

    Pfenex Inc. (NYSE-M:PFNX), San Diego, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Pfenex said HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 8/24/2015
  • Public Health England cancer news

    Public Health England, London, U.K. Business: Cancer Public Health England spun out its drug development and production activities into state-owned Porton Biopharma Ltd. The newco, which will employ over 200 people, …

    Published on 8/24/2015
  • United Therapeutics, AbbVie cancer news

    United Therapeutics Corp. (NASDAQ:UTHR), Silver Spring, Md. AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Business: Cancer United Therapeutics said it sold a rare pediatric disease Priority Review voucher to AbbVie for $350 …

    Published on 8/24/2015
  • Amarin endocrine/metabolic news

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Endocrine/Metabolic The U.S. District Court for the Southern District of New York granted preliminary relief to allowing Amarin to engage in truthful and non-…

    Published on 8/17/2015
  • Bavarian Nordic, U.S. Department of Health and Human Services infectious news

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Bavarian Nordic said HHSs Biomedical Advanced Research and Development Authority (…

    Published on 8/17/2015
  • Celgene, Hayman Capital Management cancer news

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Hayman Capital Management, Dallas, Texas Business: Cancer Celgene filed four motions with the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office requesting …

    Published on 8/10/2015
  • Regeneron, Roche, Sanofi, City of Hope antibodies news

    Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France City of Hope, Duarte, Calif. Business: Antibodies Sanofi and …

    Published on 8/10/2015
  • Synthon, Pfizer autoimmune, generics news

    Synthon B.V., Nijmegen, the Netherlands Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Autoimmune, Generics Synthon granted Pfizer exclusive, U.S. commercialization rights to a generic version of glatiramer acetate …

    Published on 8/10/2015
  • Vivus endocrine/metabolic news

    Vivus Inc. (NASDAQ:VVUS), Mountain View, Calif. Business: Endocrine/Metabolic Vivus will for the second time this year reduce sales representatives for obesity drug Qsymia phentermine/topiramate, this time to 50 from …

    Published on 8/10/2015
  • Bavarian Nordic, NIH infectious news

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark National Institutes of Health, Bethesda, Md. Business: Infectious NIHs National Institute of Allergy and Infectious Diseases (NIAID) exercised contract options under a…

    Published on 8/3/2015
  • Teva, Allergan generics news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Allergan Inc. (NYSE:AGN), Dublin, Ireland Business: Generics Allergan will divest its global generic pharmaceuticals business to Teva for $33.8 …

    Published on 8/3/2015
  • Active Biotech cancer news

    Active Biotech AB (SSE:ACTI), Lund, Sweden Business: Cancer Active Biotech will reduce its headcount by 37 (66%) to 19 employees after announcing in April that it would discontinue development of tasquinimod. The Phase …

    Published on 7/27/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a ruling and extended an …

    Published on 7/27/2015
  • AstraZeneca, Biogen, Teva pharmaceuticals news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Pharmaceuticals The companies will pay $55.5 …

    Published on 7/27/2015
  • Emergent BioSolutions, U.S. Department of Health and Human Services infectious news

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 7/27/2015
  • Allergan, Eli Lilly cancer news

    Allergan plc (NYSE:AGN), Dublin, Ireland Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Cancer The U.K. Court of Appeal ruled that Allergans pemetrexed salt formulations would indirectly infringe an Alimta …

    Published on 7/20/2015
  • Sanofi pharmaceuticals news

    Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Pharmaceuticals Sanofi will reorganize into five global business units. The realignment is Sanofis first major move since Olivier Brandicourt took over as CEO in …

    Published on 7/20/2015
  • TxCell autoimmune news

    TxCell S.A. (Euronext:TXCL), Valbonne, France Business: Autoimmune TxCell halted manufacturing at its pilot facility in Besancon, France, to ensure GMP compliance for eliminating the risk of microbial contamination in …

    Published on 7/20/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993